Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)

2.39
Delayed Data
As of May 04
 -0.21 / -8.08%
Today’s Change
2.36
Today|||52-Week Range
24.91
-76.34%
Year-to-Date

Today’s Trading

Previous close2.60
Today’s open2.58
Day’s range2.36 - 2.72
Volume974,773
Average volume (3 months)659,935
Market cap$82.3M
Dividend yield--
Data as of 4:00pm ET, 05/04/2016

Growth & Valuation

Earnings growth (last year)-88.89%
Earnings growth (this year)+19.92%
Earnings growth (next 5 years)+23.09%
Revenue growth (last year)+51.47%
P/E ratioNM
Price/Sales1.21
Price/Book0.71

Competitors

 Today’s
change
Today’s
% change
PLXProtalix Biotherapeu...+0.01+1.10%
TENXTenax Therapeutics I...-0.02-0.79%
ADMAADMA Biologics Inc-0.23-3.37%
PIRSPieris Pharmaceutica...-0.11-5.91%
Data as of 4:00pm ET, 05/04/2016

Financials

Last reporting dateMay 4, 2016
EPS forecast (this quarter)-$0.70
Annual revenue (last year)$239.9M
Annual profit (last year)-$73.3M
Net profit margin-30.57%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mary J. Szela
Chief Financial &
Administrative Officer
Gregory D. Perry
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs